Results of a phase 2 trial of an oral CXCR4 antagonist, mavorixafor, for treatment of WHIM syndrome

August 2022

Source: Blood

Publication: https://ashpublications.org/blood/article/136/26/2994/463594/Results-of-a-phase-2-trial-of-an-oral-CXCR4